Choosing the Best Approach for Patients With Favorable-Risk Metastatic Renal Cell Carcinoma 

From the 18th International Kidney Cancer Symposium November 15-16, 2019, Miami, Florida Oncologists treating patients with favorable-risk metastatic renal cell carcinoma (RCC) have multiple choices, ranging […]

Evolving Landscape of the Treatment of Metastatic Clear Cell Renal Cell Carcinoma

  Abstract: The management of advanced clear cell renal cell carcinoma (RCC) has evolved over the past decade with the introduction of targeted therapies and immune […]

Adjuvant Treatment in Renal Cell Carcinoma

  Abstract: In parallel with advances in the treatment of metastatic renal cell carcinoma (RCC), multiple adjuvant treatments have been tested for RCC. Adjuvant approaches now […]

Pazopanib in Renal Cell Carcinoma

Renal Cell Carcinoma In Focus Pazopanib in Renal Cell Carcinoma Cora N. Sternberg, MD, FACP Chief, Department of Medical Oncology, San Camillo Forlanini Hospital Rome, Italy H&O  What is the […]

Prognostic Factors in Patients Treated With VEGF-targeted Therapies

Prognostic Factors in Patients Treated With VEGF-targeted Therapies Toni K. Choueiri, MD Director, Kidney Cancer Center, Dana-Farber Cancer Institute Boston, Massachusetts H&O  What are the clinical response rates for patients with metastatic […]

Highlights from the Eigth International Kidney Cancer Symposium

Highlights from the Eigth International Kidney Cancer Symposium Thomas Hutson, DO, PharmD, FACP Director, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas TH  We now have 6 new drugs that have […]